Expert Discussion: Immunotherapy in Breast Cancer – Ready for Prime Time?

Rinnerthaler, G; Müller, V; Balic, M; Zaman, K; Dieci, MV; Breast Care (Basel). 2021; 16(2): 188-191.

Cytotoxic Compounds of Two Demosponges (Aplysina aerophoba and Spongia sp.) from the Aegean Sea

Orfanoudaki, M; Hartmann, A; Alilou, M; Mehic, N; Kwiatkowski, M; Johrer, K; Ngoc, HN; Hensel, A; Greil, R; Ganzera, M BIOMOLECULES. 2021; 11(5): 723

PAM-50 predicts local recurrence after breast cancer surgery in postmenopausal patients with ER+/HER2- disease: results from 1204 patients in the randomized ABCSG-8 trial.

Fitzal, F; Filipits, M; Fesl, C; Rudas, M; Greil, R; Balic, M; Moinfar, F; Herz, W; Dubsky, P; Bartsch, R; Ferree, S; Schaper, C; Gnant, M BRIT J SURG. 2021; 108(3): 308-314.

Prognostic and Predictive Factors in Advanced Head and Neck Squamous Cell Carcinoma.

Magnes, T; Wagner, S; Kiem, D; Weiss, L; Rinnerthaler, G; Greil, R; Melchardt, T; Int J Mol Sci. 2021; 22(9):

Docetaxel, cisplatin and 5-FU compared with docetaxel, cisplatin and cetuximab as induction chemotherapy in advanced squamous cell carcinoma of the head and neck: Results of a randomised phase II AGMT trial.

Keil, F; Hartl, M; Altorjai, G; Berghold, A; Riedl, R; Pecherstorfer, M; Mayrbäurl, B; De Vries, A; Schuster, J; Hackl, J; Füreder, T; Melchardt, T; Burian, M; Greil, R; Eur J Cancer. 2021; 151: -210.

Ramucirumab plus FOLFIRI or irinotecan as second-line therapy in advanced or metastatic gastric or gastroesophageal junction adenocarcinoma.

Schlintl, V; Huemer, F; Greil, R; Weiss, L; J Gastrointest Oncol. 2021; 12(2): 906-909.

Transferring MINDACT to Daily Routine: Implementation of the 70-Gene Signature in Luminal Early Breast Cancer – Results from a Prospective Registry of the Austrian Group Medical Tumor Therapy (AGMT)

Westphal, T; Gampenrieder, SP; Rinnerthaler, G; Balic, M; Posch, F; Dandachi, N; Hauser-Kronberger, C; Reitsamer, R; Sotlar, K; Radl, B; Suppan, C; Stoger, H; Greil, R BREAST CARE. 2021;

Cytotoxic constituents and a new hydroxycinnamic acid derivative from Leontodon saxatilis (Asteraceae, Cichorieae)

Cicek, SS; Willer, J; Preziuso, F; Sonnichsen, F; Greil, R; Girreser, U; Zidorn, C; Johrer, K RSC ADV. 2021; 11(18): 10489-10496.

Conventional versus reverse sequence of neoadjuvant epirubicin/cyclophosphamide and docetaxel: sequencing results from ABCSG-34

Bartsch, R; Singer, CF; Pfeiler, G; Hubalek, M; Stoeger, H; Pichler, A; Petru, E; Bjelic-Radisic, V; Greil, R; Rudas, M; Muy-Kheng, TM; Wette, V; Petzer, AL; Sevelda, P; Egle, D; Dubsky, PC; Filipits, M; Fitzal, F; Exner, R; Jakesz, R; Balic, M; Tinchon, C; Bago-Horvath, Z; Frantal, S; Gnant, M BRIT J CANCER. 2021;

Human Immunodeficiency Virus-2 (HIV-2): A Summary of the Present Standard of Care and Treatment Options for Individuals Living with HIV-2 in Western Europe.

Berzow, D; Descamps, D; Obermeier, M; Charpentier, C; Kaiser, R; Guertler, L; Eberle, J; Wensing, A; Sierra, S; Ruelle, J; Gomes, P; Mansinho, K; Taylor, N; Jensen, B; Döring, M; Stürmer, M; Rockstroh, J; Camacho, R; Clin Infect Dis. 2021; 72(3):503-509